Next Article in Journal
Anticancer Activity of Sea Cucumber Triterpene Glycosides
Previous Article in Journal
Emergence and Epidemiology of Ciguatera in the Coastal Cities of Southern China
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Marine Drugs
Volume 13
Issue 3
10.3390/md13031185
marinedrugs-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Biotransfer of β-N-Methylamino-l-alanine (BMAA) in a Eutrophicated Freshwater Lake

by
Sandra Lage
1,
Heléne Annadotter
2,
Ulla Rasmussen
1 and
Sara Rydberg
1,*
1
Department of Ecology, Environment and Plant Sciences, Stockholm University, 10654 Stockholm, Sweden
2
Regito AB, 28022 Vittsjö, Sweden
*
Author to whom correspondence should be addressed.
Mar. Drugs 2015, 13(3), 1185-1201; https://doi.org/10.3390/md13031185
Submission received: 25 November 2014 / Revised: 10 February 2015 / Accepted: 15 February 2015 / Published: 2 March 2015
Browse Figures
Versions Notes

Abstract

:
β-N-Methylamino-l-alanine (BMAA), a neurotoxic non-protein amino acid, plays a significant role as an environmental risk factor in neurodegenerative diseases, such as amyotrophic lateral sclerosis. BMAA producers occur globally, colonizing almost all habitats and represent species from distinct phytoplanktonic groups, i.e., cyanobacteria, diatoms, and dinoflagellates. Bioaccumulation of BMAA in invertebrate and vertebrate organisms has also been registered around the globe. In the Baltic Sea, BMAA has been detected in several commercial fish species, raising the question of the bioaccumulation of BMAA in Swedish limnic systems. Here we find the presence of BMAA in water samples from Lake Finjasjön and identify its bioaccumulation patterns in both plankti-benthivorous and piscivorous fish, according to fish species, total weight, gender, and season of collection. For the first time, a large number of fish individuals were used in order to draw conclusions on BMAA bioaccumulation in a closed ecological community based on a statistical approach. We may, therefore, conclude that feeding patterns (plankti-benthivorous) and increased age of fish may lead to a higher tissue concentration of BMAA.

1. Introduction

β-Methylamino-l-alanine (BMAA), a non-protein amino acid, was first isolated from the seeds of Cycas circinalis, currently known as Cycas micronesica Hill, in Guam in the Western Pacific Ocean [1,2]. There, BMAA was linked to the high rate of amyotrophic lateral sclerosis/parkinsonism-dementia complex (ALS-PDC) among the indigenous people of this island [3,4]. In 2003, BMAA was found to be produced by the cyanobacterium Nostoc sp. living symbiotically with the coralloid roots of the cycad trees [5]. There are several potential mechanisms by which BMAA may cause neurological injury [6,7,8] and environmental exposures may contribute to the development of neurodegenerative disorders [9,10].
BMAA is produced by species representative of cyanobacteria, diatoms, and dinoflagellates [11,12,13]. These species are globally distributed and present in terrestrial, brackish, freshwater, and marine habitats. BMAA has been detected in desert dust in the Persian Gulf [14], several water bodies, including urban waters in the Netherlands [15], 11 freshwater lakes and one brackish water body in Britain [16], cyanobacteria isolates from South African freshwater impoundments [17], springs from a Gobi Desert oasis [18], and marine and freshwater ecosystems in China [19]. Phytoplankton surface blooms are also a recurring phenomenon in the Baltic Sea [20,21]. In the summer months (June–August), these blooms are dominated by the cyanobacterial genera Nodularia and Aphanizomenon, which have also been demonstrated to produce BMAA [11,22,23]. In the Baltic Sea, larger blooms of diatoms are present in spring (March–May). Jonasson et al. [23] found that zooplankton, which naturally feed on cyanobacteria, contain clearly higher levels of BMAA than do the BMAA producers. In addition, several fish tissues were found to contain up to 200 times higher concentrations of BMAA than did the cyanobacteria. The results obtained in this Baltic Sea study revealed, for the first time, that BMAA was biotransferred in an aquatic ecosystem outside Guam.
The Baltic Sea is not the only source of commercial fish in Sweden, a country containing many lakes, including some of the biggest in Europe. In 2011, the four biggest Swedish lakes, i.e., lakes Mälaren, Hjälmaren, Vättern, and Vänern, together contributed 1484 metric tons of commercial fish. This can be compared with the 130,000 metric tons of fish caught in the Baltic Sea, approximately 90,000 tons of which were used as fodder-fish [24]. The large amount of commercial fish used for human consumption from freshwater lakes is of major concern, as Swedish society might be exposed to BMAA through such fish consumption.
To infer any possible transfer of BMAA within Swedish limnic ecosystems, Lake Finjasjön was selected as a eutrophicated model lake. The small size of the lake favors detailed research into the several trophic levels and their interrelationships, therefore, providing a greater understanding of BMAA bioaccumulation patterns. This shallow lake has been suffering from eutrophication since the early 20th century and consequently is occasionally affected by major blooms of toxic cyanobacterial species (i.e., Microcystis) [25]. Over the years, several restoration schemes were unsuccessfully implemented, until 1992 when a top-down control strategy restored the native fauna and flora composition, leading to reduced microcystin-producing cyanobacteria [25]. Lake Finjasjön currently has a healthy balance between cyanobacteria and diatoms year round, with increased surface blooms of cyanobacteria between July and September. Although the microcystin-producing cyanobacteria are no longer a problem, several of the cyanobacterial species (i.e., Aphanizomenon klebahnii, Microcystis aeruginosa, and Anabaena sp.) included in the phytoplanktonic composition in Finjasjön are reportedly BMAA-producing species [11,26].
Noteworthy is that BMAA can potentiate neuronal injury induced by other neurotoxic agents, even if both compounds alone have non-toxic concentrations [7,27]. One of these neurotoxic agents is mercury, which will be analyzed together with BMAA.
The present study aims to confirm BMAA production by the phytoplanktonic community (i.e., water samples) and the transfer of BMAA to several fish species at different trophic levels in Lake Finjasjön. Considering the several reports of BMAA occurrence in aquatic systems [23,28,29,30] it is of interest to clarify BMAA bioaccumulation trends in the different fish tissues and fish species through a systematic study with a high number of individuals, which is the main purpose of this study.

2. Results

BMAA was detected in three of the four water samples from Lake Finjasjön (Table 1). All positive samples had similar total (i.e., free plus protein-associated) BMAA concentrations.
Table
Table 1. BMAA levels in water samples collected in Lake Finjasjön, April 2012.
Table 1. BMAA levels in water samples collected in Lake Finjasjön, April 2012.
BMAA, µg·g−1 DW ± SD *
Sample 10.002 ± 0.001
Sample 20.006 ± 0.002
Sample 3ND
Sample 40.004 ± 0.001
ND = not detected; * Mean BMAA concentrations ± Standard deviation, n = 3 analytical replicates.
Fish tissues (i.e., brain, muscle, liver, and kidney) were screened for BMAA using UPLC-MS/MS. Quantifiable BMAA peaks were found in 16 of 32 (50%) brain samples from Abramis brama, in 8 of 29 (28%) brain samples from Perca fluviatilis, in 3 of 22 (14%) brain samples from Esox lucius, in 4 of 29 (14%) brain samples from Sander lucioperca, and in 9 of 24 (38%) brain samples from Rutilus rutilus (Table 2). A relatively higher percentage of positive brain samples of A. brama and R. rutilus were noted in which the BMAA concentrations were 0.0007–0.0152 µg·g−1 dry weight (DW) and 0.0010–0.0064 µg·g−1 DW, respectively. The highest BMAA concentration, 0.0283 µg·g−1 DW (shown as an outlier), was detected in the brain of a female P. fluviatilis caught in spring 2012 (Figure 1).
Table
Table 2. Positive BMAA results in selected fish species from Lake Finjasjön: Abramis brama (Bream), n = 32; Perca fluviatilis (Perch), n = 29; Esox lucius (Pike), n = 22; Sander lucioperca (Pike-perch), n = 29; and Rutilus rutilus (Roach), per season of collection, gender and fish tissue, n of positive samples/total n.
Table 2. Positive BMAA results in selected fish species from Lake Finjasjön: Abramis brama (Bream), n = 32; Perca fluviatilis (Perch), n = 29; Esox lucius (Pike), n = 22; Sander lucioperca (Pike-perch), n = 29; and Rutilus rutilus (Roach), per season of collection, gender and fish tissue, n of positive samples/total n.
FallSpring
FemaleMaleFemaleMale
BrainMuscleBrainMuscleBrainMuscleBrainMuscle
Abramis brama0/00/03/72/77/144/146/113/11
Perca fluviatilis2/70/71/21/25/203/200/00/0
Esox lucius0/10/11/61/61/91/91/60/6
Sander lucioperca0/10/13/103/101/163/160/20/2
Rutilus rutilus4/50/52/41/43/150/150/00/0
Marinedrugs 13 01185 g001 1024
Figure 1. BMAA concentrations detected and quantified in brain tissue of selected fish species from Lake Finjasjön; distribution by species: Abramis brama (Bream), n = 32; Perca fluviatilis (Perch), n = 29; Esox lucius (Pike), n = 22; Sander lucioperca (Pike-perch), n = 29; and Rutilus rutilus (Roach), n = 24; median, 75th quartile, maximum, and outliers.
Figure 1. BMAA concentrations detected and quantified in brain tissue of selected fish species from Lake Finjasjön; distribution by species: Abramis brama (Bream), n = 32; Perca fluviatilis (Perch), n = 29; Esox lucius (Pike), n = 22; Sander lucioperca (Pike-perch), n = 29; and Rutilus rutilus (Roach), n = 24; median, 75th quartile, maximum, and outliers.
Marinedrugs 13 01185 g001
Regarding the dominance of females over males among the fish samples (i.e., female, n = 88 vs. male, n = 48), a comparable percentage of positive brain samples was found for each gender (i.e., 26% and 35% for female and male samples, respectively), which could imply a higher trend for BMAA presence in male brains than in brains dissected from females (Table 2). However, the highest BMAA concentrations were found in female brains.
The seasonal distribution of BMAA-containing brain samples is comparable to the gender distribution. Although the number of fish collected in spring was more than the double the number collected in fall, the percentage of brain samples containing BMAA was 37% in the fall and 26% in the spring (Table 2). This may imply a higher chance of BMAA being present in fish caught in fall, though higher BMAA concentrations were found in fish caught in spring.
From the total of 136 individuals of A. brama, P. fluviatilis, E. lucius, S. lucioperca, and R. rutilus, only 22 individuals (i.e., 16%) contained quantifiable BMAA in their muscle tissue (Table 2 and Table 3). As observed for the brain samples, the highest percentage of positive BMAA results found in the muscle samples was in A. brama individuals. However, no major tendency could be distinguished due to the small number of positive samples.
Table
Table 3. BMAA concentrations in quantifiable samples of muscle tissue from selected fish species from Lake Finjasjön: Abramis brama (Bream), n = 32; Perca fluviatilis (Perch), n = 29; Esox lucius (Pike), n = 22; Sander lucioperca (Pike-perch), n = 29; and Rutilus rutilus (Roach), n = 24.
Table 3. BMAA concentrations in quantifiable samples of muscle tissue from selected fish species from Lake Finjasjön: Abramis brama (Bream), n = 32; Perca fluviatilis (Perch), n = 29; Esox lucius (Pike), n = 22; Sander lucioperca (Pike-perch), n = 29; and Rutilus rutilus (Roach), n = 24.
Collection SeasonSpeciesBMAA, µg·g−1 DW ± SD *
Fall 2011Abramis brama0.00103 ± 0.00027 (n = 2)
Perca fluviatilis0.00008 (n = 1)
Esox lucius0.00046 (n = 1)
Sander lucioperca0.00127 ± 0.00054 (n = 3)
Rutilus rutilus0.00018 (n = 1)
Spring 2012Abramis brama0.00200 ± 0.00173 (n = 7)
Perca fluviatilis0.00159 ± 0.00152 (n = 3)
Esox lucius0.00026 (n = 1)
Sander lucioperca0.00642 ± 0.00253 (n = 3)
* Mean BMAA concentrations in quantifiable samples of fish muscle tissue ± Standard deviation, n = biological replicates.
All kidney and liver samples tested negative for BMAA. Inconclusive BMAA peaks were detected in a few liver samples from Abramis brama and Perca fluviatilis caught in fall 2011; however, the peaks were too low in intensity to be taken to indicate positive samples. This could be dependent on the matrix effect, since liver is a major site of lipid storage [31,32], and not because the samples were truly BMAA negative. The BMAA isomer DAB was detected in a few kidney samples and, along with BMAA, in almost all positive samples (data not shown).
From the six fish species (i.e., Tinca tinca, Lota lota, Salmo trutta trutta, Gymnocephalus cernua, Scardinius erythrophthalmus, and Anguilla anguilla) caught exclusively in spring 2012, only individuals of G. cernua, T. tinca, and A. anguilla contained quantifiable peaks of BMAA in brain and muscle tissues (Table 4). G. cernua was the species with a higher percentage of positive results.
The Spearman’s rank test indicated no significant correlation between the BMAA concentration in brain and muscle tissues (p = 0.5026).
Table
Table 4. BMAA concentrations in quantifiable brain and muscle samples from the six fish species collected exclusively in spring 2012 in Lake Finjasjön: Gymnocephalus cernua (Ruffe), n = 15; Tinca tinca (Tench), n = 15; and Anguilla anguilla (Eel), n = 15.
Table 4. BMAA concentrations in quantifiable brain and muscle samples from the six fish species collected exclusively in spring 2012 in Lake Finjasjön: Gymnocephalus cernua (Ruffe), n = 15; Tinca tinca (Tench), n = 15; and Anguilla anguilla (Eel), n = 15.
TissueSpeciesBMAA, µg·g−1 DW ± SD *
BrainGymnocephalus cernua0.00864 ± 0.00476 (n = 3)
Tinca tinca0.00141 (n = 1)
Anguilla anguilla0.02202 ± 0.00884 (n = 2)
MuscleGymnocephalus cernua0.00320 ± 0.00329 (n = 4)
Tinca tinca0.00561 (n = 1)
* Mean BMAA concentrations in quantifiable samples of fish tissues ± Standard deviation, n = biological replicates.
A suitable linear model explaining the distribution of BMAA concentration in the fish brain contains the fish total weight variable (p = 0.0082) and the fish species variable (p = 0.0268). However, due to the high amount of negative BMAA samples (i.e., zeros) this model can only explain 9.13% of the variance. Regarding the fish total weight variable, this model predicts that in a group of individuals of the same species, the heaviest one has a higher chance of containing higher amounts of BMAA in its brain.
The distribution of BMAA in the brain samples of the species E. lucius (p = 0.00063) and S. lucioperca (p = 0.00494) differs significantly from the distribution observed in A. brama. R. rutilus and P. fluviatilis do not display any significant difference from A. brama. BMAA is therefore more frequently found in A. brama, R. rutilus, and P. fluviatilis than in E. lucius and S. lucioperca.
The limit of detection (LOD) and limit of quantification (LOQ) were determined based on the signal-to-noise ratio (S/N) of the chromatographic peaks [33]. The LOD was calculated for the diagnostic product ion of BMAA (i.e., m/z 459.1 > 258.09) and the LOQ for the general BMAA product ion (i.e., m/z 459.1 > 119.08). The LOD was established when the S/N was higher than 3.0 for the diagnostic product ion of BMAA (i.e., m/z 459.1 > 258.09). For the general BMAA product ion (i.e., m/z 459.1 > 119.08), the BMAA peak displayed an S/N between 10 and 30, so the LOQ was described as equal to the LOD. For Spirulina, both LOD and LOQ were 0.8 ng·mL−1 and the calibration curve had an r2 = 0.99 (Figure 2a). In the fish samples (in both brain and muscle tissues), both LOD and LOQ were also 0.8 ng∙mL−1. The regression lines revealed an r2 of 0.98 for the brain tissue and 0.99 for the muscle tissue (Figure 2b,c). BMAA was only considered to be present in a sample when a peak had an S/N value higher than 4.0, was observed in both product ions, the BMAA retention time at m/z 459.1 > 119.08 and m/z 459.1 > 258.09 chromatograms was 2.85 ± 0.12 min and the ratio between the ions m/z 459.1 > 119.08 and m/z 459.1 > 258.09 were 5.5 ± 1.0. Retention time and ions ratio was matrix dependent. Although all BMAA quantifications were performed in the second elute of the solid-phase extraction purified sample, occasionally BMAA peaks were also detected in the first elute.
Marinedrugs 13 01185 g002 1024
Figure 2. BMAA standard curves of (a) Spirulina powder, (b) Atlantic horse mackerel (Trachurus trachurus) brain and (c) muscle tissue; with six concentration points (0.8, 2, 7, 13, 27 and 100 ng·mL−1) prepared in triplicate over 2.5 mg of protein from each matrix.
Figure 2. BMAA standard curves of (a) Spirulina powder, (b) Atlantic horse mackerel (Trachurus trachurus) brain and (c) muscle tissue; with six concentration points (0.8, 2, 7, 13, 27 and 100 ng·mL−1) prepared in triplicate over 2.5 mg of protein from each matrix.
Marinedrugs 13 01185 g002
D3-BMAA recovery (i.e., SPE and derivatization) in the blank samples was 54.9 ± 2.0% for the brain and 14.3 ± 3.5% for the muscle tissues. In the environmental contaminated fish samples the D3-BMAA losses were equivalent to recovery experiment in the blank samples; 34.3 ± 6.2% for the brain and 10.7 ± 7.5% for the muscle tissues. A matrix effect was also detected, when the D3-BMAA signal response in the matrix was compared to the signal in the Borate buffer. Although these values were lower than those presented in previous studies of cyanobacteria and mussels [34,35,36,37], to the best of our knowledge, this is the first time that D3-BMAA recovery has been tested in fish brain and muscle tissues.
The average value of mercury in S. lucioperca was 0.091 mg·kg−1 wet weight (WW) in males and 0.095 in females (Table 5). In A. brama, the average value was 0.040 mg·kg−1 WW in both males and females. The EU’s maximum permitted mercury concentration in S. lucioperca and A. brama is 0.5 mg·kg−1 WW, meaning that the mercury levels detected in these fish from Lake Finjasjön are much lower than the EU-permitted concentration.
Table
Table 5. Weight and mercury concentrations in the muscle tissue of Abramis brama (Bream), n = 10, and Sander lucioperca (Pike-perch), n = 10, collected in fall 2011 in Lake Finjasjön.
Table 5. Weight and mercury concentrations in the muscle tissue of Abramis brama (Bream), n = 10, and Sander lucioperca (Pike-perch), n = 10, collected in fall 2011 in Lake Finjasjön.
Abramis BramaSander Lucioperca
Males n = 5Females n = 5Males n = 5Females n = 5
Weight (kg)Maximum1.3871.0451.1511.118
Minimum0.8320.8700.7850.875
Mean1.1780.9410.9351.048
Standard deviation0.2160.0820.1690.098
Mercury concentration (mg·kg−1 WW)Maximum0.0440.0510.1000.120
Minimum0.0300.0320.0810.071
Mean0.0400.0400.0910.095
Standard deviation0.0060.0080.0070.019

3. Discussion

The water samples collected in Lake Finjasjön contained BMAA in three of four samples. This reveals a BMAA exposure route to fish at higher trophic levels inhabiting both pelagic and benthic water masses—thereby sustaining BMAA biomagnification in various niches.
The cyanobacteria Aphanizomenon klebahnii, previous established as a BMAA producer [11], was the potential BMAA source in Lake Finjasjön during our sampling period. Nevertheless, the recent findings of BMAA producers among the diatom and dinoflagellate groups [12,13] raise the question of whether the other phytoplankton species present (i.e., Ceratium hirundinella, Cryptomonas sp., Fragilaria crotonensis, and Asterionella formosa) [26] might also be sources of BMAA. The BMAA concentrations detected are equivalent to those found in cyanobacteria collected in the Baltic Sea [23] and in representative diatom species from the Swedish West Coast [12].
A divergent BMAA pattern can be distinguished between the piscivorous and the plankti-benthivorous fish in Lake Finjasjön. The plankti-benthivorous fish, which had the higher frequency of BMAA, are dominated by A. brama and R. rutilus. Both these cyprinidae species inhabit the same niche, have similar diets [38], and can moreover hybridize with each other [39,40].
A. brama generally feed on benthic animals [38,41], whereas R. rutilus feed on detritus, zooplankton, plants, and benthic animals [42]. A. brama undergo an ontogenetic habitat and diet shift from foraging on zooplankton in the pelagic habitats to feeding on invertebrates in the bottom sediment. The size of the bream, whose diet shifts from pelagic to benthic feeding, is highly variable and can vary between lakes [43,44].
Between 1992 and 1994, 430 tons of A. brama and R. rutilus were removed from Lake Finjasjön as a food-web manipulation measure to restore the native fauna and flora composition. After reducing the population of large-sized A. brama, a shift was registered in the feeding habits of A. brama and R. rutilus in earlier life stages, with an increase in feeding on benthic resources [43]. Since 1992 to 2007 these large-scale reductions of A. brama and R. rutilus were performed, intermittently, by trawling. Since 2010 and to date (2014), A. brama and R. rutilus have been removed annually, by fyke-netting during the spring spawning and in the fall by ring-seining. The relative proportions of piscivorous and plankti-benthivorous fish have varied since these mass removals started. In 2012, when this study was performed, a test fishery identified balance in the fish community, which comprised equal proportions of piscivorous and plankti-benthivorous fish.
It is not unexpected to observe that A. brama individuals have higher concentrations of BMAA given that they continue to feed on benthic prey, where BMAA exposure is anticipated, throughout their various size classes, while older R. rutilus move into open-water to feed [43], potentially reducing exposure later in life. Thus, older individuals are most likely to have higher concentrations of BMAA and this difference will be more profound in fish species that have more uniform BMAA exposure as they grow.
In the next trophic level, the pelagic and piscivorous fish species are E. lucius and S. lucioperca. Some of the BMAA-positive brain samples representing these species have BMAA concentrations higher than approximately 75% of A. brama and R. rutilus individuals but below the maximum concentrations found in A. brama. Therefore, BMAA can bioaccumulate along the fish trophic chain in Lake Finjajön. In accordance with earlier observations in the Baltic Sea [23], south Florida coastal waters [28,29], and Lake Taihu [30], in Lake Finjasjön the presence of BMAA is more frequent in bottom-feeding than pelagic organisms. This again suggests that cyanobacteria and/or other phytoplankton (i.e., diatoms and dinoflagellates) may descend in the water column during the bloom decline, and/or that benthic phytoplankton have higher BMAA concentrations than do the surface blooms of phytoplankton. BMAA was absent from the brain tissue of S. lucioperca collected in the Baltic Sea [23]; however, the brain tissue of S. lucioperca from Lake Finjasjön contains quantifiable and relatively high amounts of BMAA. This discrepancy may be due to the large array of prey available to pelagic fish in the Baltic Sea and the large dimensions of the Baltic Sea compared with the confined Lake Finjasjön, where S. lucioperca may not be able to avoid ingesting BMAA-contaminated prey.
P. fluviatilis is a strictly carnivorous fish that undergoes ontogenetic diet shifts from zooplanktivorous, benthivorous, to piscivorous stages [45] and interacts competitively with R. rutilus [46,47,48]. In Lake Finjasjön, small P. fluviatilis (<80 mm) individuals consume 78% of the zooplankton and 22% of the benthic prey, while the larger individuals (>180 mm) feed almost exclusively on fish [43].
Two of the highest BMAA concentrations were registered in brain samples of P. fluviatilis females of approximately 200 g (theoretically large individuals). These BMAA concentrations probably represent the cumulative effect of earlier zooplankton and benthic feeding together with later feeding on BMAA-contaminated prey fish. The similar frequency of BMAA-containing P. fluviatilis individuals and BMAA-containing A. brama and R. rutilus individuals is possibly related to their common benthivorous diet.
Along with the species, the total weight of the individual was statistically significant in relation to BMAA concentrations, the heavier, and likely older, individuals of the same species containing higher BMAA concentrations. Hence, in a system in which BMAA is continuously bioavailable, an organism will bioaccumulate BMAA throughout its life, so older individuals will contain higher concentrations of BMAA.
The influence of organism weight on BMAA quantity can also explain the recorded variances according to gender and season. Females may have higher growth rates [49] and are often larger than males [50,51,52]. As females therefore may consume larger amounts of potentially BMAA-contaminated prey, this may explain the greater amount of BMAA in their brain tissue. As most individuals caught in spring were females, this season also yielded higher concentrations of BMAA.
However, if only the frequency, and not the concentration, of BMAA is taken into account, there is a slightly higher likelihood of BMAA being found in male individuals and in fish captured in fall. This is understandable considering that most fish species, females in particular, tend to reduce their food intake during sexual maturation and throughout the spawning season [53,54].
Overall, BMAA is found less frequently and at lower concentrations in fish muscle tissue than in brain tissue, though A. brama is still the fish species with higher percentage of individuals containing BMAA. As suggested earlier, this must be related to this species’ almost exclusively benthivorous diet. The heterogeneous distribution of BMAA between fish tissues was also observed in the Baltic Sea study and was suggested to be related to BMAA’s tendency for protein association [23]. In the present study, however, approximately four times less BMAA was recovered from muscle than from brain tissue. Also the BMAA concentration in brain and muscle tissues were not significant correlated, therefore no major conclusions can be drawn and this issue requires further investigation.
Of the six fish species collected exclusively in spring, only G. cernua and T. tinca contained BMAA in both brain and muscle tissues, while A. anguilla contained BMAA in only the brain tissue. Based on previous results, the bioaccumulation of BMAA in G. cernua and T. tinca was predictable, because both species feed mostly on benthic food resources [55,56,57] and typically live above soft sediments where they presumably also forage [58]. Another important factor is that the G. cernua population tends to increase with increased eutrophication [57]. A. anguilla, another bottom-dwelling fish, feeds on the whole aquatic fauna, depending on prey size and availability [59]. Although no definitive conclusion can be drawn based on just two brain samples of A. anguilla, these samples did contain some of the highest BMAA concentrations found in the whole study.
The overall concentrations of BMAA in fish tissues from Lake Finjasjön were similar to those in fish tissues from the Baltic Sea [23], though lower than those found in fish from south Florida coastal waters i.e., 58 ± 41 µg·g−1 WW in muscle, 588 ± 81 µg·g−1 WW in liver, and 1450 ± 687 µg·g−1 WW in kidney [29] or in fish from Lake Taihu in China, where the values of BMAA in fish muscle range from 0.07 ± 0.021 to 35.91 ± 13.40 µg·g−1 DW [30]. This variance might be due to biological factors, such as Swedish aquatic systems being less affected by BMAA, though a more likely explanation is methodological differences between studies.
An excessive protein-to-derivative ratio during derivatization has earlier been suggested [60] to be the main cause for the low BMAA concentrations detected in the Baltic Sea [23]—consequently this criticism may be applied to the present study since the same extraction method has been used. To exclude this possibility, D3-BMAA was added prior to the SPE step to determine the BMAA recoveries from the SPE step as well as the derivatization (all according to suggestions by Cohen [60]). Additionally the same stable isotope was added to the quantified Finjasjön fish samples. Both tests reveal a relatively high D3-BMAA loss in brain and muscle fish tissues. Therefore, the BMAA concentrations presented are a fraction of its actual amount. Nevertheless as this fraction percentage is now known, it will allow a direct comparison of BMAA results across samples and research groups. In addition, during the development of the extraction method [61] each step of the procedure was optimized and examined and it was then concluded that the method requires protein concentrations no lower than 2.5 mg due to sample losses during the SPE cleanup. Thus, we conclude that low BMAA concentrations are most probably not due to high protein-to-derivative ratios. The detection of both BMAA and mercury in the muscle tissue of A. brama and S. lucioperca is notable, as BMAA at non-toxic concentrations potentiates mercury neurotoxicity [27]; the synergetic neurotoxicity of BMAA and mercury may therefore threaten human health despite mercury concentrations being below the EU-permitted level.
Taken together, the data presented here indicate the widespread natural occurrence of BMAA in Lake Finjasjön. This finding, together with BMAA and mercury co-occurrence, raises questions as to the current potential public health risk, since the fish species analyzed are frequently caught and consumed by the surrounding population in the city of Hässleholm. It is therefore urgent to understand which phytoplankton species produce BMAA in Swedish limnic systems and to verify the synergistic effects of BMAA with mercury and other toxins and metals present in the relevant fish species, in order to understand the BMAA bioaccumulation pattern in the trophic chain and better protect consumers.

4. Experimental Section

4.1. Sampling and Sampling Area Description

The lake used as a eutrophicated model was the shallow Lake Finjasjön (56°08′ N, 13°42′ E) located in southern Sweden near the city of Hässleholm. Lake Finjasjön, at an elevation of 43.2 m above sea level, has a surface area of 10.4 km2, average and maximum depths of 3.8 and 12.2 m, respectively, a global retention time of six months, and a catchment area of 260 km2. The lake’s surface water temperature averages 19.8 °C in the summer (June–August), reaching a maximum of 22.7 °C [26].
Four water samples were collected from Lake Finjasjön in April 2012. 500 mL water bottles were submerged and filled with surface water. Fish species, selected according to their position in the trophic chain and habitat, were collected from Lake Finjasjön throughout two seasons, i.e., fall (September and October) 2011 and spring (April) 2012. The species were: Abramis brama (Bream) n = 32, Perca fluviatilis (Perch) n = 29, Esox lucius (Pike) n = 22, Sander lucioperca (Pike-perch) n = 29, and Rutilus rutilus (Roach) n = 24. In spring 2012, additional fish species were collected: Tinca tinca (Tench) n = 15, Lota lota (Burbot) n = 6, Salmo trutta trutta (Trout) n = 6, Gymnocephalus cernua (Ruffe) n = 15, Scardinius erythrophthalmus (Common Rudd) n = 10, and Anguilla anguilla (Eel) n = 15. Fish specimens were immediately frozen (−20 °C) and transported to the laboratory.

4.2. Sample Preparation

Water samples were lyophilized using a CoolSafe freeze-dryer (SCANVAC, Stockholm, Sweden) at −110 °C and stored at −20 °C until BMAA extraction.
Frozen fish samples were thawed at room temperature and then weighed and dissected into brain, muscle, liver, and kidney tissue. Fish tissue samples were ground finely and frozen at −20 °C until use. The fish gender was also registered.

4.3. BMAA Sample Extraction

BMAA was extracted from water and fish tissue samples (i.e., brain, muscle, liver, and kidney) according to the procedure of Spacil, et al. [61] with minor alterations. Samples were dissolved in 80% methanol (80/20 methanol/water, v/v). Cell lysis was ensured by subjecting the cell suspension to three freeze/thaw cycles in liquid nitrogen, followed by sonication (Sonopuls, Model HD 2070; Bandelin Electronic, Berlin, Germany) for three 45-s cycles at 70% intensity. To minimize protein degradation, all samples were kept in an ice-water bath during sonication and allowed to cool between each sonication cycle. Protein concentration was determined after cell lysis using Bio-Rad RC/DC kit (Bio-Rad, Sundbyberg, Sweden). Samples were hydrolyzed in 6 mmol·L−1 HCl for 20 h at 110 °C and then lyophilized using a freeze-dryer at −110 °C. Lyophilized samples were reconstituted with 20 mmol·L−1 HCl, and 2.5 mg of protein from each sample was then purified using solid-phase extraction (SPE) (Isolute HCX-3, 100 mg; Biotage, Uppsala, Sweden). Prior to equilibration 1 mL of MeOH was passed through the SPE column. The SPE column was then equilibrated by two consecutive additions of 1 mL 0.1% formic acid. Next, 0.2 mL of sample (i.e., 2.5 mg of protein) was loaded together with 0.1% formic acid (0.8 mL). The SPE column was washed with 1 mL 0.1% formic acid and the first elute (1 mL of 0.1% formic acid in 25% MeOH) was discarded. Then the second elute (1 mL of 2% NH4+ in MeOH) from each sample was lyophilized using a miVac centrifugal vacuum concentrator (Genevac, Ipswich, UK) connected to a freeze-dryer and stored at −20 °C.
Lyophilized samples were then reconstituted with 20 µL of 20 mmol·L−1 HCl solution, transferred to glass vials (Waters, Milford, MA, USA) for LC analysis, and derivatized with AccQ-Tag using a WAT052880 AccQ-Tag kit (Waters), i.e., 70 μL of borate buffer and 30 μL of AQC. Ultra performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) analysis was performed within 2–10 h of samples derivatization.

4.4. Ultra Performance Liquid Chromatography Tandem Mass Spectrometry

Analysis was performed using an Acquity UPLC coupled to a Xevo-TQ-MS (Waters). The separation was performed with an AccQ-Tag Ultra C18 column (100 mm × 2.1 mm, 1.7 µm particle size; Waters) using a binary pump: Eluent A was 0.01% formic acid in 0.05% ammonia in water; eluent B was 0.01% formic acid in methanol. The gradient used was as follows: 0.1% B, 0.54 min; 45% B, 4.00 min; 100% B, 4.10 min; and 0.1% B, 4.70–6.00 min. The flow was diverted to the mass spectrometer between 1.2 and 3.5 min to minimize contamination of the interface; otherwise it was diverted to waste.
Ionization was performed in positive ion mode and the mass analyzer was run in selected reaction monitoring (SRM) scan mode using the following transitions to distinguish BMAA from its isomers N-(2-aminoethyl) glycine (AEG) and 4-diaminobutyric acid (DAB): general to all three analytes, 459.1 > 119.1; DAB diagnostic fragment, 459.1 > 188.1; AEG diagnostic fragment, 459.1 > 214.1; BMAA diagnostic fragment, 459.1 > 258.1 and D3-BMAA fragment, 462.20 > 122.1. To further ensure positive identification of BMAA, the retention time and fragmentation ratio of fragments 119.1/258.1 were controlled.
All settings were optimized for BMAA detection as follows: cone voltage, 30 V; source temperature, 150 °C; desolvation temperature, 550 °C, cone gas flow 20 L∙h-1, desolvation gas flow, 1000 L∙h-1, collision gas flow, 0.15 mL∙min-1, collision energy, 26 V. MassLynx V4.1 software (Waters) was used to analyze the acquired chromatographic data. BMAA was identified using a highly selective UPLC-MS/MS method that distinguishes BMAA from its isomers AEG and DAB in biological samples.

4.5. Quantification Method and Recovery

Spirulina powder (Go for Life AB, Stockholm, Sweden) previously determined to contain no detectable amounts of BMAA was selected as a negative control and used as matrix when water samples were quantified. The standard curve has six concentration points (0.8, 2, 7, 13, 27 and 100 ng·mL−1) prepared in triplicate over 2.5 mg of Spirulina powder protein.
Atlantic horse mackerel (Trachurus trachurus) collected in the Atlantic Ocean in April 2012 was dissected and extracted using the same procedure as used for all fish samples. After proving to be negative for BMAA, brain and muscle tissues were used as a negative control and as matrix for brain and muscle tissue quantification. Both standard curves have six concentration points (0.8, 2, 7, 13, 27 and 100 ng·mL−1) prepared in triplicate over 2.5 mg of protein of each matrix. All standards were added to the blank matrices just before derivatization.
To test the BMAA recovery, twelve replicates of T. trachurus (six brain and six muscle), were prepared. To three samples each of brain and muscle tissue, a fixed amount of D3-BMAA internal standard (0.8 ng) was added before solid-phase extraction over 2.5 mg of protein. D3-BMAA was added to the other six samples just after the sample preparation but before derivatization.
In addition, to predict BMAA losses, the same fixed amount of D3-BMAA was added to every quantified sample prepared during the study before solid-phase extraction.

4.6. Statistical Analysis

To ensure accurate statistical analysis, only data for the fish species collected in both seasons were used, consequently the sample size of the analyzed fish species was analogous.
To detect any significant (p < 0.05) influence of the variables season of collection, fish gender, total weight, and species on the response variable (i.e., BMAA concentration in brain tissue) distribution, several parametric linear models were executed after the transformation of numerical variables and achievement of Gaussian distributions. Anova-Chi-Square tests were also performed to confirm linear model results.
Although the distribution of BMAA concentrations in brain satisfied the parametric test assumptions, the distribution of BMAA concentrations in the muscle tissue did not. Therefore the non-parametric Spearman’s rank correlation coefficient was used to test whether the BMAA concentrations in brain and muscle tissues were correlated (p < 0.05).
Statistical analysis was carried out on R Statistical Software (Foundation for Statistical Computing, Vienna, Austria).

4.7. Mercury Analysis

Muscle samples of Sander lucioperca (Pike-perch) and Abramis brama (Bream) collected from Lake Finjasjön in fall 2011 were tested for mercury. The individuals weighed approximately 1 kg each; 10 individuals of each fish species were selected, 50% of which were males and 50% females.
Total mercury was analyzed using the SS-EN 16277:2012 method [62], which is developed by the Swedish Standards Institute. The method is entitled Determination of mercury by cold-vapor atomic absorption spectrometry (CVAAS) after microwave pressure digestion (extraction with 65% nitric acid and 30% hydrogen peroxide).The analyses were performed at the laboratory of Eurofins Environment Sweden AB, Lidköping, Sweden.

Acknowledgments

We thank the Swedish Research Council Formas for financial support and the Baltic 2020 and Olle Engkvist Byggmästare foundations for funding the Acquity UPLC coupled to Xevo-TQ-MS (Waters) through the MiMeBS grant awarded to Birgitta Bergman.

Author Contributions

Sara Rydberg conceived and designed the experiment. Sandra Lage performed the experiment and analyzed the data. Heléne Annadotter collected all field samples. Sandra Lage, Sara Rydberg, Ulla Rasmussen and Heléne Annadotter wrote the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Vega, A.; Bell, A. α-Amino-β-methylaminopropionic acid, a new amino acid from seeds of Cycas circinalis. Phytochemistry 1967, 6, 759–762. [Google Scholar] [CrossRef]
  2. Hill, K.D. The Cycas rumphii complex (cycadaceae) in New Guinea and the Western Pacific. Aust. Syst. Bot 1994, 7, 543–567. [Google Scholar] [CrossRef]
  3. Spencer, P.S. Guam ALS/Parkinsonism-dementia: A long-latency neurotoxic disorder caused by “slow toxin(s)” in food? Can. J. Neurol. Sci. 1987, 14, 347–357. [Google Scholar] [PubMed]
  4. Spencer, P.S.; Kisby, G.E.; Ludolph, A.C. Slow toxins, biologic markers, and long-latency neurodegenerative disease in the western Pacific region. Neurology 1991, 41, 62–66. [Google Scholar] [CrossRef] [PubMed]
  5. Cox, P.A.; Banack, S.A.; Murch, S.J. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam. Proc. Natl. Acad. Sci. USA 2003, 100, 13380–13383. [Google Scholar] [CrossRef] [PubMed]
  6. Rao, S.D.; Banack, S.A.; Cox, P.A.; Weiss, J.H. BMAA selectively injures motor neurons via AMPA/kainate receptor activation. Exp. Neurol. 2006, 201, 244–252. [Google Scholar] [CrossRef] [PubMed]
  7. Lobner, D.; Piana, P.M.T.; Salous, A.K.; Peoples, R.W. Beta-N-methylamino-l-alanine enhances neurotoxicity through multiple mechanisms. Neurobiol. Dis. 2007, 25, 360–366. [Google Scholar] [CrossRef] [PubMed]
  8. Liu, X.Q.; Rush, T.; Ciske, J.; Lobner, D. Selective death of cholinergic neurons induced by beta-methylamino-l-alanine. Neuroreport 2010, 21, 55–58. [Google Scholar] [CrossRef] [PubMed]
  9. Murch, S.J.; Cox, P.A.; Banack, S.A.; Steele, J.C.; Sacks, O.W. Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam. Acta Neurol. Scand. 2004, 110, 267–269. [Google Scholar] [CrossRef] [PubMed]
  10. Pablo, J.; Banack, S.A.; Cox, P.A.; Johnson, T.E.; Papapetropoulos, S.; Bradley, W.G.; Buck, A.; Mash, D.C. Cyanobacterial neurotoxin BMAA in ALS and Alzheimer’s disease. Acta Neurol. Scand. 2009, 120, 216–225. [Google Scholar] [CrossRef] [PubMed]
  11. Cox, P.A.; Banack, S.A.; Murch, S.J.; Rasmussen, U.; Tien, G.; Bidigare, R.R.; Metcalf, J.S.; Morrison, L.F.; Codd, G.A.; Bergman, B. Diverse taxa of cyanobacteria produce beta-N-methylamino-l-alanine, a neurotoxic amino acid. Proc. Natl. Acad. Sci. USA 2005, 102, 5074–5078. [Google Scholar] [CrossRef] [PubMed]
  12. Jiang, L.Y.; Eriksson, J.; Lage, S.; Jonasson, S.; Shams, S.; Mehine, M.; Ilag, L.L.; Rasmussen, U. Diatoms: A novel source for the neurotoxin BMAA in aquatic environments. PLoS One 2014, 9, e84578. [Google Scholar] [CrossRef] [PubMed]
  13. Lage, S.; Costa, P.R.; Moita, T.; Eriksson, J.; Rasmussen, U.; Rydberg, S.J. BMAA in shellfish from two Portuguese transitional water bodies suggests the marine dinoflagellate Gymnodinium catenatum as a potential BMAA source. Aquat. Toxicol. 2014, 152, 131–138. [Google Scholar] [CrossRef] [PubMed]
  14. Cox, P.A.; Richer, R.; Metcalf, J.S.; Banack, S.A.; Codd, G.A.; Bradley, W.G. Cyanobacteria and BMAA exposure from desert dust: A possible link to sporadic ALS among Gulf War veterans. Amyotroph. Later. Scler. 2009, 10 (Suppl. S2), 109–117. [Google Scholar] [CrossRef]
  15. Faassen, E.J.; Gillissen, F.; Zweers, H.A.J.; Lürling, M. Determination of the neurotoxins BMAA (β-N-methylamino-l-alanine) and DAB (α-,γ-diaminobutyric acid) by LC-MSMS in Dutch urban waters with cyanobacterial blooms. Amyotroph. Later. Scler. 2009, 10, 79–84. [Google Scholar] [CrossRef]
  16. Metcalf, J.S.; Banack, S.A.; Lindsay, J.; Morrison, L.F.; Cox, P.A.; Codd, G.A. Co-occurrence of beta-N-methylamino-l-alanine, a neurotoxic amino acid with other cyanobacterial toxins in British waterbodies, 1990–2004. Environ. Microbiol. 2008, 10, 702–708. [Google Scholar] [CrossRef] [PubMed]
  17. Esterhuizen, M.; Downing, T.G. Beta-N-methylamino-l-alanine (BMAA) in novel South African cyanobacterial isolates. Ecotoxicol. Environ. Saf. 2008, 71, 309–313. [Google Scholar] [CrossRef] [PubMed]
  18. Craighead, D.; Metcalf, J.S.; Banack, S.A.; Amgalan, L.; Reynolds, H.V.; Batmunkh, M. Presence of the neurotoxic amino acids beta-N-methylamino-l-alanine (BMAA) and 2,4-diamino-butyric acid (DAB) in shallow springs from the Gobi Desert. Amyotroph. Later. Scler. 2009, 10 (Suppl. S2), 96–100. [Google Scholar] [CrossRef]
  19. Li, A.F.; Tian, Z.J.; Li, J.; Yu, R.C.; Banack, S.A.; Wang, Z.Y. Detection of the neurotoxin BMAA within cyanobacteria isolated from freshwater in China. Toxicon 2010, 55, 947–953. [Google Scholar] [CrossRef] [PubMed]
  20. Boesch, D.; Hecky, R.; Chair, C.O.; Schindler, D.; Seitzinger, S. Eutrophication of Swedish Seas; Swedish Environmental Protection Agency: Valhallavägen, Sweden, 2006; pp. 1–68. [Google Scholar]
  21. Gallon, J.R.; Evans, A.M.; Jones, D.A.; Albertano, P.; Congestri, R.; Bergman, B.; Gundersen, K.; Orcutt, K.M. Maximum rates of N2 fixation and primary production are out of phase in a developing cyanobacterial bloom in the Baltic Sea. Limnol. Oceanogr. 2002, 47, 1514–1521. [Google Scholar] [CrossRef]
  22. Degerholm, J.; Gundersen, K.; Bergman, B.; Söderbäck, E. Phosphorus-limited growth dynamics in two Baltic Sea cyanobacteria, Nodularia sp. and Aphanizomenon sp. FEMS Microbiol. Ecol. 2006, 58, 323–332. [Google Scholar] [CrossRef] [PubMed]
  23. Jonasson, S.; Eriksson, J.; Berntzon, L.; Spacil, Z.; Ilag, L.L.; Ronnevi, L.O.; Rasmussen, U.; Bergman, B. Transfer of a cyanobacterial neurotoxin within a temperate aquatic ecosystem suggests pathways for human exposure. Proc. Natl. Acad. Sci. USA 2010, 107, 9252–9257. [Google Scholar] [CrossRef] [PubMed]
  24. Ericson, J. Saltsjöfiskets Fångster under 2012 Definitiva Uppgifter; Swedish Agency for Marine and Water Management: Gothenburg, Sweden, 2013; pp. 1–14. [Google Scholar]
  25. Annadotter, H.; Cronberg, G.; Aagren, R.; Lundstedt, B.; Nilsson, P.-Ǻ.; Ströbeck, S. Multiple techniques for lake restoration. In The Ecological Bases for Lake and Reservoir Management; Harper, D., Brierley, B., Ferguson, A.D., Phillips, G., Eds.; Springer Netherlands: Berlin, Germany, 1999; Volume 136, pp. 77–85. [Google Scholar]
  26. Annadotter, H.; Forssblad, J. Limnologisk Undersökning av Finjasjön; Hässleholms kommun, Tekniska kontoret & RegitoAB: Vittsjö, Sweden, 2011; pp. 1–71. [Google Scholar]
  27. Rush, T.; Liu, X.; Lobner, D. Synergistic toxicity of the environmental neurotoxins methylmercury and beta-N-methylamino-l-alanine. Neuroreport 2012, 23, 216–219. [Google Scholar] [CrossRef] [PubMed]
  28. Brand, L.E.; Pablo, J.; Compton, A.; Hammerschlag, N.; Mash, D.C. Cyanobacterial blooms and the occurrence of the neurotoxin beta-N-methylamino-l-alanine (BMAA) in South Florida Aquatic Food Webs. Harmful Algae 2010, 9, 620–635. [Google Scholar] [CrossRef] [PubMed]
  29. Mondo, K.; Hammerschlag, N.; Basile, M.; Pablo, J.; Banack, S.A.; Mash, D.C. Cyanobacterial neurotoxin beta-N-methylamino-l-alanine (BMAA) in shark fins. Mar. Drugs 2012, 10, 509–520. [Google Scholar] [CrossRef] [PubMed]
  30. Jiao, Y.; Chen, Q.; Chen, X.; Wang, X.; Liao, X.; Jiang, L.; Wu, J.; Yang, L. Occurrence and transfer of a cyanobacterial neurotoxin β-methylamino-l-alanine within the aquatic food webs of Gonghu Bay (Lake Taihu, China) to evaluate the potential human health risk. Sci. Total Environ. 2014, 468–469, 457–463. [Google Scholar] [CrossRef] [PubMed]
  31. Love, R.M. The Chemical Biology of Fishes; Academic Press: London, UK, 1970. [Google Scholar]
  32. Shulman, G.E. Life Cycles of Fish; John Wiley and Sons: New York, NY, USA, 1974. [Google Scholar]
  33. Guidance for Industry—Bioanalytical Method Validation; US Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM): Silver Spring, MD, USA, 2001.
  34. Faassen, E.J.; Gillissen, F.; Lurling, M. A comparative study on three analytical methods for the determination of the neurotoxin BMAA in cyanobacteria. PLoS One 2012, 7, e36667. [Google Scholar] [CrossRef] [PubMed]
  35. Faassen, E. Presence of the neurotoxin BMAA in aquatic ecosystems: What do we really know? Toxins 2014, 6, 1109–1138. [Google Scholar] [CrossRef] [PubMed]
  36. Jiang, L.Y.; Johnston, E.; Aberg, K.M.; Nilsson, U.; Ilag, L.L. Strategy for quantifying trace levels of BMAA in cyanobacteria by LC/MS/MS. Anal. Bioanal. Chem. 2013, 405, 1283–1292. [Google Scholar] [CrossRef] [PubMed]
  37. Salomonsson, M.; Hansson, A.; Bondesson, U. Development and in-house validation of a method for quantification of BMAA in mussels using dansyl chloride derivatization and ultra performance liquid chromatography tandem mass spectrometry. Anal. Methods 2013, 5, 4865–4874. [Google Scholar] [CrossRef]
  38. Lessmark, O. Competition between Perch (Perca fluviatilis) and Roach (Rutilus rutilus) in South Swedish Lakes. Ph.D. Thesis, Institute of Limnology, University of Lund, Lund, Sweden, 1983. [Google Scholar]
  39. Wood, A.B.; Jordan, D.R. Fertility of roach × bream hybrids, Rutilus rutilus (L.) × Abramis brama (L.), and their identification. J. Fish Biol. 1987, 30, 249–261. [Google Scholar] [CrossRef]
  40. Kopiejewska, W.; Terlecki, J.; Chybowski, L. Histology of gonads in hybrids of roach Rutilus rutilus (L.) and bream Abramis brama (L.) upon sexual maturity. Zool. Poloniae 2004, 49, 149–158. [Google Scholar]
  41. Persson, A.; Stenberg, M. Linking patch-use behavior, resource density, and growth expectations in fish. Ecology 2006, 87, 1953–1959. [Google Scholar] [CrossRef] [PubMed]
  42. Persson, L. Food composition and the significance of detritus and algae to intraspecific competition in roach Rutilus rutilus in a shallow eutrophic lake. Oikos 1983, 41, 118–125. [Google Scholar] [CrossRef]
  43. Persson, A.; Hansson, L. Diet shift in fish following competitive release. Can. J. Fish. Aquat. Sci. 1999, 56, 70–78. [Google Scholar] [CrossRef]
  44. Persson, A.; Brönmark, C. Foraging capacities and effects on competitive release on ontogenetic diet shift in bream, Abramis brama. Oikos 2002, 97, 271–281. [Google Scholar] [CrossRef]
  45. Persson, L. Food consumption and competition between age classes in a perch Perca fluviatilis population in a shallow eutrophic lake. Oikos 1983, 40, 197–207. [Google Scholar] [CrossRef]
  46. Persson, L. Effects of intra- and interspecific competition on dynamics and size structure of a perch Perca fluviatilis and a roach Rutilus rutilus population. Oikos 1983, 41, 126–132. [Google Scholar] [CrossRef]
  47. Nurminen, L.; Pekcan-Hekim, Z.; Horppila, J. Feeding efficiency of planktivorous perch Perca fluviatilis and roach Rutilus rutilus in varying turbidity: an individual-based approach. J. Fish Biol. 2010, 76, 1848–1855. [Google Scholar] [CrossRef] [PubMed]
  48. Persson, L.; Greenberg, L.A. Juvenile competitive bottlenecks: The perch (Perca fluviatilis)—Roach (Rutilus rutilus) interaction. Ecology 1990, 71, 44–56. [Google Scholar] [CrossRef]
  49. Cowx, I.G. Review of the methods for estimating fish population size from survey removal data. Aquac. Res. 1983, 14, 67–82. [Google Scholar] [CrossRef]
  50. Roff, D. An allocation model of growth and reproduction in fish. Can. J. Fish. Aquat. Sci. 1983, 40, 1395–1404. [Google Scholar] [CrossRef]
  51. Roff, D. The Evolution of Life Histories: Theory and Analysis; Chapman and Hall: New York, NY, USA, 1992. [Google Scholar]
  52. Parker, G.A. The evolution of sexual size dimorphism in fish. J. Fish Biol. 1992, 41 (Suppl. B), 1–20. [Google Scholar] [CrossRef]
  53. Lal, B.; Singh, T.P. Changes in tissue lipid levels in the freshwater catfish Clarias batrachus associated with the reproductive cycle. Fish Physiol. Biochem. 1987, 3, 191–201. [Google Scholar] [CrossRef] [PubMed]
  54. Nassour, I.; Léger, C.L. Deposition and mobilisation of body fat during sexual maturation in female trout ( Salmo gairdneri Richardson). Aquat. Living Resour. 1989, 2, 153–159. [Google Scholar] [CrossRef]
  55. Bergman, E. Changes in abundance of two percids, Perca fluviatilis and Gymnocephalus cernuus, along a productivity gradient: Relations to feeding strategies and competitive abilities. Can. J. Fish Aquat. Sci. 1991, 48, 536–545. [Google Scholar] [CrossRef]
  56. Bergman, E.; Greenberg, L.A. Competition between a planktivore, a benthivore, and a species with ontogenetic diet shifts. Ecology 1994, 75, 1233–1245. [Google Scholar] [CrossRef]
  57. Kottelat, M.; Freyhof, J. Handbook of European Freshwater Fishes; Kottelat Publications: Cornol, Switzerland, 2007. [Google Scholar]
  58. Ogle, D.H. A synopsis of the biology and life history of ruffe. J. Gt. Lakes Res. 1998, 24, 170–185. [Google Scholar] [CrossRef]
  59. Deelder, C.L. Synopsis of Biological Data on the Eel Anguilla Anguilla (Linnaeus, 1758); Netherlands Institute for Fishery Development: Rome, Italy, 1984. [Google Scholar]
  60. Cohen, S.A. Analytical techniques for the detection of α-amino-β-methylaminopropionic acid. Analyst 2012, 137, 1991–2005. [Google Scholar] [CrossRef] [PubMed]
  61. Spacil, Z.; Eriksson, J.; Jonasson, S.; Rasmussen, U.; Ilag, L.L.; Bergman, B. Analytical protocol for identification of BMAA and DAB in biological samples. Analyst 2010, 135, 127–132. [Google Scholar] [CrossRef] [PubMed]
  62. SIS/TK 435. Animal Feeding Stuffs—Determination of Mercury by Cold-Vapour Atomic Absorption Spectrometry (CVAAS) after Microwave Pressure Digestion (Extraction with 65% Nitric Acid and 30% Hydrogen Peroxide); BSI: London, UK, 2012. Available online: http://www.sis.se/en/agriculture/animal-feeding-stuffs/ss-en-162772012 (accessed on 7 July 2012).

Share and Cite

MDPI and ACS Style

Lage, S.; Annadotter, H.; Rasmussen, U.; Rydberg, S. Biotransfer of β-N-Methylamino-l-alanine (BMAA) in a Eutrophicated Freshwater Lake. Mar. Drugs 2015, 13, 1185-1201. https://doi.org/10.3390/md13031185

AMA Style

Lage S, Annadotter H, Rasmussen U, Rydberg S. Biotransfer of β-N-Methylamino-l-alanine (BMAA) in a Eutrophicated Freshwater Lake. Marine Drugs. 2015; 13(3):1185-1201. https://doi.org/10.3390/md13031185

Chicago/Turabian Style

Lage, Sandra, Heléne Annadotter, Ulla Rasmussen, and Sara Rydberg. 2015. "Biotransfer of β-N-Methylamino-l-alanine (BMAA) in a Eutrophicated Freshwater Lake" Marine Drugs 13, no. 3: 1185-1201. https://doi.org/10.3390/md13031185

Article Metrics

Back to TopTop